Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
1500 28 32 28 32 B-lower_bound
/ 32 33 32 33 I-lower_bound
mm^3 33 37 33 37 I-lower_bound

Active 0 6 38 44 B-chronic_disease
coronary 7 15 45 53 I-chronic_disease
artery 16 22 54 60 I-chronic_disease
disease 23 30 61 68 I-chronic_disease

Active 0 6 69 75 O
or 7 9 76 78 O
clinically 10 20 79 89 O
significant 21 32 90 101 O
cardiac 33 40 102 109 B-chronic_disease
disease 41 48 110 117 I-chronic_disease

Alanine 0 7 118 125 O
aminotransferase 8 24 126 142 I-clinical_variable
( 25 26 143 144 I-clinical_variable
ALT 26 29 144 147 I-clinical_variable
) 29 30 147 148 I-clinical_variable
and 31 34 149 152 O
aspartate 35 44 153 162 B-clinical_variable
aminotransferase 45 61 163 179 I-clinical_variable
( 62 63 180 181 I-clinical_variable
AST 63 66 181 184 I-clinical_variable
) 66 67 184 185 I-clinical_variable
= 68 69 186 187 O
< 69 70 187 188 O
2.5 71 74 189 192 B-upper_bound
x 75 76 193 194 I-upper_bound
ULN 77 80 195 198 I-upper_bound
(= 81 83 199 201 O
< 83 84 201 202 O
5 85 86 203 204 O
x 87 88 205 206 O
ULN 89 92 207 210 O
for 93 96 211 214 O
subjects 97 105 215 223 O
with 106 110 224 228 O
liver 111 116 229 234 O
involvement 117 128 235 246 O
of 129 131 247 249 O
their 132 137 250 255 O
cancer 138 144 256 262 O
) 144 145 262 263 O

Alkaline 0 8 264 272 B-clinical_variable
phosphatase 9 20 273 284 I-clinical_variable
limit 21 26 285 290 I-clinical_variable
= 27 28 291 292 O
< 28 29 292 293 O
2.5 30 33 294 297 B-upper_bound
x 34 35 298 299 I-upper_bound
ULN 36 39 300 303 I-upper_bound
(= 40 42 304 306 O
< 42 43 306 307 O
5 44 45 308 309 O
x 46 47 310 311 O
ULN 48 51 312 315 O
for 52 55 316 319 O
subjects 56 64 320 328 O
with 65 69 329 333 O
liver 70 75 334 339 O
involvement 76 87 340 351 O
of 88 90 352 354 O
their 91 96 355 360 O
cancer 97 103 361 367 B-cancer
) 103 104 367 368 O

Any 0 3 369 372 O
hemorrhage 4 14 373 383 O
or 15 17 384 386 O
bleeding 18 26 387 395 O
event 27 32 396 401 O
grade 33 38 402 407 O
3 39 40 408 409 O
within 41 47 410 416 O
4 48 49 417 418 B-upper_bound
weeks 50 55 419 424 I-upper_bound
prior 56 61 425 430 I-upper_bound
to 62 64 431 433 O
registration 65 77 434 446 O

Any 0 3 447 450 O
malabsorption 4 17 451 464 B-chronic_disease
condition 18 27 465 474 O

Cardiac 0 7 475 482 B-chronic_disease
arrhythmias 8 19 483 494 I-chronic_disease
requiring 20 29 495 504 O
anti 30 34 505 509 B-treatment
- 34 35 509 510 I-treatment
arrhythmic 35 45 510 520 I-treatment
therapy 46 53 521 528 I-treatment
other 54 59 529 534 O
than 60 64 535 539 O
beta 65 69 540 544 B-treatment
blockers 70 78 545 553 I-treatment
or 79 81 554 556 O
digoxin 82 89 557 564 B-treatment

Concurrent 0 10 565 575 O
anti 11 15 576 580 B-treatment
- 15 16 580 581 I-treatment
cancer 16 22 581 587 I-treatment
therapy 23 30 588 595 I-treatment
( 31 32 596 597 O
chemotherapy 32 44 597 609 B-treatment
, 44 45 609 610 O
surgery 46 53 611 618 B-treatment
, 53 54 618 619 O
immunotherapy 55 68 620 633 B-treatment
, 68 69 633 634 O
biologic 70 78 635 643 B-treatment
therapy 79 86 644 651 I-treatment
, 86 87 651 652 O
or 88 90 653 655 O
tumor 91 96 656 661 B-treatment
embolization 97 109 662 674 I-treatment
) 109 110 674 675 O
other 111 116 676 681 O
than 117 121 682 686 O
study 122 127 687 692 O
treatment 128 137 693 702 O
( 138 139 703 704 O
regorafenib 139 150 704 715 B-treatment
) 150 151 715 716 O

Congestive 0 10 717 727 B-chronic_disease
heart 11 16 728 733 I-chronic_disease
failure 17 24 734 741 I-chronic_disease
- 25 26 742 743 O
New 27 30 744 747 O
York 31 35 748 752 O
Heart 36 41 753 758 O
Association 42 53 759 770 O
> 54 55 771 772 O
class 56 61 773 778 O
II 62 64 779 781 O

Dehydration 0 11 782 793 B-clinical_variable
> 12 13 794 795 O
grade 14 19 796 801 B-lower_bound
1 20 21 802 803 I-lower_bound

Eastern 0 7 804 811 B-clinical_variable
Cooperative 8 19 812 823 I-clinical_variable
Oncology 20 28 824 832 I-clinical_variable
Group 29 34 833 838 I-clinical_variable
( 35 36 839 840 I-clinical_variable
ECOG 36 40 840 844 I-clinical_variable
) 40 41 844 845 I-clinical_variable
performance 42 53 846 857 I-clinical_variable
status 54 60 858 864 I-clinical_variable
( 61 62 865 866 I-clinical_variable
PS 62 64 866 868 I-clinical_variable
) 64 65 868 869 I-clinical_variable
0 66 67 870 871 B-lower_bound
or 68 70 872 874 O
1 71 72 875 876 B-upper_bound

Evidence 0 8 877 885 O
of 9 11 886 888 O
abdominal 12 21 889 898 B-chronic_disease
fistula 22 29 899 906 I-chronic_disease
, 29 30 906 907 O
gastrointestinal 31 47 908 924 B-chronic_disease
( 48 49 925 926 I-chronic_disease
GI 49 51 926 928 I-chronic_disease
) 51 52 928 929 I-chronic_disease
perforation 53 64 930 941 I-chronic_disease
or 65 67 942 944 O
intraabdominal 68 82 945 959 B-chronic_disease
abscess 83 90 960 967 I-chronic_disease

Evidence 0 8 968 976 O
of 9 11 977 979 O
significant 12 23 980 991 O
central 24 31 992 999 B-chronic_disease
nervous 32 39 1000 1007 I-chronic_disease
system 40 46 1008 1014 I-chronic_disease
disease 47 54 1015 1022 I-chronic_disease
including 55 64 1023 1032 O
seizure 65 72 1033 1040 B-chronic_disease
disorder 73 81 1041 1049 I-chronic_disease
requiring 82 91 1050 1059 O
medication 92 102 1060 1070 O
, 102 103 1070 1071 O
symptomatic 104 115 1072 1083 B-cancer
metastatic 116 126 1084 1094 I-cancer
brain 127 132 1095 1100 I-cancer
or 133 135 1101 1103 O
meningeal 136 145 1104 1113 B-cancer
tumors 146 152 1114 1120 I-cancer

Evidence 0 8 1121 1129 O
or 9 11 1130 1132 O
history 12 19 1133 1140 O
of 20 22 1141 1143 O
bleeding 23 31 1144 1152 B-chronic_disease
diathesis 32 41 1153 1162 I-chronic_disease
or 42 44 1163 1165 O
coagulopathy 45 57 1166 1178 B-chronic_disease

Exceptions 0 10 1179 1189 O
include 11 18 1190 1197 O
cervical 19 27 1198 1206 B-cancer
cancer 28 34 1207 1213 I-cancer
in 35 37 1214 1216 I-cancer
- 37 38 1216 1217 I-cancer
situ 38 42 1217 1221 I-cancer
, 42 43 1221 1222 O
treated 44 51 1223 1230 O
basal 52 57 1231 1236 B-cancer
cell 58 62 1237 1241 I-cancer
carcinoma 63 72 1242 1251 I-cancer
, 72 73 1251 1252 O
or 74 76 1253 1255 O
superficial 77 88 1256 1267 B-cancer
bladder 89 96 1268 1275 I-cancer
tumor 97 102 1276 1281 I-cancer

Hemoglobin 0 10 1282 1292 B-clinical_variable
> 11 12 1293 1294 O
9 13 14 1295 1296 B-lower_bound
g 15 16 1297 1298 I-lower_bound
/ 16 17 1298 1299 I-lower_bound
dL 17 19 1299 1301 I-lower_bound

Histologically 0 14 1302 1316 O
confirmed 15 24 1317 1326 O
angiosarcoma 25 37 1327 1339 B-cancer

History 0 7 1340 1347 O
of 8 10 1348 1350 O
organ 11 16 1351 1356 B-treatment
allograft 17 26 1357 1366 I-treatment
( 27 28 1367 1368 O
including 28 37 1368 1377 O
corneal 38 45 1378 1385 B-treatment
transplant 46 56 1386 1396 I-treatment
) 56 57 1396 1397 O

International 0 13 1398 1411 B-clinical_variable
normalized 14 24 1412 1422 I-clinical_variable
ratio 25 30 1423 1428 I-clinical_variable
( 31 32 1429 1430 I-clinical_variable
INR)/partial 32 44 1430 1442 I-clinical_variable
thromboplastin 45 59 1443 1457 I-clinical_variable
time 60 64 1458 1462 I-clinical_variable
( 65 66 1463 1464 I-clinical_variable
PTT 66 69 1464 1467 I-clinical_variable
) 69 70 1467 1468 I-clinical_variable
< 71 72 1469 1470 O
1.5 73 76 1471 1474 B-upper_bound
x 77 78 1475 1476 I-upper_bound
ULN 79 82 1477 1480 I-upper_bound

Interstitial 0 12 1481 1493 B-chronic_disease
lung 13 17 1494 1498 I-chronic_disease
disease 18 25 1499 1506 I-chronic_disease
with 26 30 1507 1511 O
ongoing 31 38 1512 1519 O
signs 39 44 1520 1525 O
and 45 48 1526 1529 O
symptoms 49 57 1530 1538 O
at 58 60 1539 1541 O
the 61 64 1542 1545 O
time 65 69 1546 1550 O
of 70 72 1551 1553 O
registration 73 85 1554 1566 O

Known 0 5 1567 1572 O
history 6 13 1573 1580 O
of 14 16 1581 1583 O
human 17 22 1584 1589 B-chronic_disease
immunodeficiency 23 39 1590 1606 I-chronic_disease
virus 40 45 1607 1612 I-chronic_disease
( 46 47 1613 1614 I-chronic_disease
HIV 47 50 1614 1617 I-chronic_disease
) 50 51 1617 1618 I-chronic_disease
infection 52 61 1619 1628 I-chronic_disease
or 62 64 1629 1631 O
current 65 72 1632 1639 O
chronic 73 80 1640 1647 O
or 81 83 1648 1650 O
active 84 90 1651 1657 O
hepatitis 91 100 1658 1667 B-chronic_disease
B 101 102 1668 1669 I-chronic_disease
or 103 105 1670 1672 I-chronic_disease
C 106 107 1673 1674 I-chronic_disease
infection 108 117 1675 1684 I-chronic_disease
requiring 118 127 1685 1694 O
treatment 128 137 1695 1704 O
with 138 142 1705 1709 O
antiviral 143 152 1710 1719 B-treatment
therapy 153 160 1720 1727 I-treatment

Life 0 4 1728 1732 B-clinical_variable
expectancy 5 15 1733 1743 I-clinical_variable
of 16 18 1744 1746 O
at 19 21 1747 1749 O
least 22 27 1750 1755 O
4 28 29 1756 1757 B-lower_bound
months 30 36 1758 1764 I-lower_bound

Lipase 0 6 1765 1771 B-clinical_variable
= 7 8 1772 1773 O
< 8 9 1773 1774 O
1.5 10 13 1775 1778 B-upper_bound
x 14 15 1779 1780 I-upper_bound
the 16 19 1781 1784 I-upper_bound
ULN 20 23 1785 1788 I-upper_bound

Low 0 3 1789 1792 O
dose 4 8 1793 1797 O
aspirin 9 16 1798 1805 B-clinical_variable
(= 17 19 1806 1808 O
< 19 20 1808 1809 O
100 21 24 1810 1813 B-upper_bound
mg 25 27 1814 1816 I-upper_bound
daily 28 33 1817 1822 I-upper_bound
) 33 34 1822 1823 O

Low 0 3 1824 1827 O
dose 4 8 1828 1832 O
warfarin 9 17 1833 1841 B-treatment
( 18 19 1842 1843 O
1 19 20 1843 1844 O
mg 21 23 1845 1847 O
orally 24 30 1848 1854 O
, 30 31 1854 1855 O
once 32 36 1856 1860 O
daily 37 42 1861 1866 O
) 42 43 1866 1867 O
with 44 48 1868 1872 O
prothrombin 49 60 1873 1884 B-clinical_variable
time 61 65 1885 1889 I-clinical_variable
( 66 67 1890 1891 I-clinical_variable
PT)-international 67 84 1891 1908 I-clinical_variable
normalized 85 95 1909 1919 I-clinical_variable
ratio 96 101 1920 1925 I-clinical_variable
( 102 103 1926 1927 I-clinical_variable
INR 103 106 1927 1930 I-clinical_variable
) 106 107 1930 1931 I-clinical_variable
= 108 109 1932 1933 O
< 109 110 1933 1934 O
1.5 111 114 1935 1938 B-upper_bound
x 115 116 1939 1940 I-upper_bound
ULN 117 120 1941 1944 I-upper_bound
is 121 123 1945 1947 O
permitted 124 133 1948 1957 O

Major 0 5 1958 1963 O
surgical 6 14 1964 1972 O
procedure 15 24 1973 1982 O
, 24 25 1982 1983 O
open 26 30 1984 1988 B-treatment
biopsy 31 37 1989 1995 I-treatment
, 37 38 1995 1996 O
or 39 41 1997 1999 O
significant 42 53 2000 2011 O
traumatic 54 63 2012 2021 O
injury 64 70 2022 2028 O
within 71 77 2029 2035 O
28 78 80 2036 2038 B-upper_bound
days 81 85 2039 2043 I-upper_bound
before 86 92 2044 2050 O
registration 93 105 2051 2063 O

Ongoing 0 7 2064 2071 O
infection 8 17 2072 2081 B-clinical_variable
> 18 19 2082 2083 O
grade 20 25 2084 2089 B-lower_bound
2 26 27 2090 2091 I-lower_bound

Patients 0 8 2092 2100 O
who 9 12 2101 2104 O
are 13 16 2105 2108 O
prophylactically 17 33 2109 2125 B-treatment
treated 34 41 2126 2133 I-treatment
with 42 46 2134 2138 O
an 47 49 2139 2141 O
agent 50 55 2142 2147 O
such 56 60 2148 2152 O
as 61 63 2153 2155 O
warfarin 64 72 2156 2164 B-treatment
or 73 75 2165 2167 O
heparin 76 83 2168 2175 B-treatment
will 84 88 2176 2180 O
be 89 91 2181 2183 O
allowed 92 99 2184 2191 O
to 100 102 2192 2194 O
participate 103 114 2195 2206 O
provided 115 123 2207 2215 O
that 124 128 2216 2220 O
no 129 131 2221 2223 O
prior 132 137 2224 2229 O
evidence 138 146 2230 2238 O
of 147 149 2239 2241 O
underlying 150 160 2242 2252 O
abnormality 161 172 2253 2264 O
in 173 175 2265 2267 O
coagulation 176 187 2268 2279 O
parameters 188 198 2280 2290 O
exists 199 205 2291 2297 O

Patients 0 8 2298 2306 O
with 9 13 2307 2311 O
pheochromocytoma 14 30 2312 2328 B-cancer

Patients 0 8 2329 2337 O
with 9 13 2338 2342 O
severe 14 20 2343 2349 B-chronic_disease
hepatic 21 28 2350 2357 I-chronic_disease
impairment 29 39 2358 2368 I-chronic_disease
( 40 41 2369 2370 O
Child 41 46 2370 2375 B-clinical_variable
- 46 47 2375 2376 I-clinical_variable
Pugh 47 51 2376 2380 I-clinical_variable
class 52 57 2381 2386 O
C 58 59 2387 2388 O
) 59 60 2388 2389 O

Platelet 0 8 2390 2398 B-clinical_variable
count 9 14 2399 2404 I-clinical_variable
> 15 16 2405 2406 O
100000 17 23 2407 2413 B-lower_bound
/ 23 24 2413 2414 I-lower_bound
mm^3 24 28 2414 2418 I-lower_bound

Pleural 0 7 2419 2426 B-chronic_disease
effusion 8 16 2427 2435 I-chronic_disease
or 17 19 2436 2438 O
ascites 20 27 2439 2446 B-chronic_disease
that 28 32 2447 2451 O
causes 33 39 2452 2458 O
respiratory 40 51 2459 2470 O
compromise 52 62 2471 2481 O
( 63 64 2482 2483 O
> 64 65 2483 2484 O
= 65 66 2484 2485 O
grade 67 72 2486 2491 B-lower_bound
2 73 74 2492 2493 I-lower_bound
dyspnea 75 82 2494 2501 B-clinical_variable
) 82 83 2501 2502 O

Presence 0 8 2503 2511 O
of 9 11 2512 2514 O
a 12 13 2515 2516 O
non 14 17 2517 2520 B-chronic_disease
- 17 18 2520 2521 I-chronic_disease
healing 18 25 2521 2528 I-chronic_disease
wound 26 31 2529 2534 I-chronic_disease
, 31 32 2534 2535 O
non 33 36 2536 2539 B-chronic_disease
- 36 37 2539 2540 I-chronic_disease
healing 37 44 2540 2547 I-chronic_disease
ulcer 45 50 2548 2553 I-chronic_disease
, 50 51 2553 2554 O
or 52 54 2555 2557 O
bone 55 59 2558 2562 B-chronic_disease
fracture 60 68 2563 2571 I-chronic_disease

Prior 0 5 2572 2577 O
use 6 9 2578 2581 O
of 10 12 2582 2584 O
regorafenib 13 24 2585 2596 B-treatment

Prior 0 5 2597 2602 O
use 6 9 2603 2606 O
of 10 12 2607 2609 O
sorafenib 13 22 2610 2619 B-treatment

Progressive 0 11 2620 2631 B-chronic_disease
disease 12 19 2632 2639 I-chronic_disease
under 20 25 2640 2645 O
last 26 30 2646 2650 O
palliative 31 41 2651 2661 B-treatment
therapy 42 49 2662 2669 I-treatment
with 50 54 2670 2674 O
a 55 56 2675 2676 O
history 57 64 2677 2684 O
of 65 67 2685 2687 O
prior 68 73 2688 2693 O
ifosfamide 74 84 2694 2704 B-treatment

Prophylactic 0 12 2705 2717 O
doses 13 18 2718 2723 O
of 19 21 2724 2726 O
heparin 22 29 2727 2734 B-treatment

Radiation 0 9 2735 2744 B-treatment
directed 10 18 2745 2753 O
at 19 21 2754 2756 O
target 22 28 2757 2763 O
lesion 29 35 2764 2770 B-chronic_disease
within 36 42 2771 2777 O
28 43 45 2778 2780 B-upper_bound
days 46 50 2781 2785 I-upper_bound
of 51 53 2786 2788 O
registration 54 66 2789 2801 O

Renal 0 5 2802 2807 B-chronic_disease
failure 6 13 2808 2815 I-chronic_disease
requiring 14 23 2816 2825 O
hemo 24 28 2826 2830 B-treatment
- 28 29 2830 2831 I-treatment
or 29 31 2831 2833 I-treatment
peritoneal 32 42 2834 2844 I-treatment
dialysis 43 51 2845 2853 I-treatment

Serum 0 5 2854 2859 B-clinical_variable
creatinine 6 16 2860 2870 I-clinical_variable
= 17 18 2871 2872 O
< 18 19 2872 2873 O
1.5 20 23 2874 2877 B-upper_bound
x 24 25 2878 2879 I-upper_bound
the 26 29 2880 2883 I-upper_bound
ULN 30 33 2884 2887 I-upper_bound

Subjects 0 8 2888 2896 O
( 9 10 2897 2898 O
men 10 13 2898 2901 B-gender
and 14 17 2902 2905 I-gender
women 18 23 2906 2911 I-gender
) 23 24 2911 2912 O
of 25 27 2913 2915 O
childbearing 28 40 2916 2928 O
potential 41 50 2929 2938 O
must 51 55 2939 2943 O
agree 56 61 2944 2949 B-contraception_consent
to 62 64 2950 2952 I-contraception_consent
use 65 68 2953 2956 I-contraception_consent
adequate 69 77 2957 2965 I-contraception_consent
contraception 78 91 2966 2979 I-contraception_consent
beginning 92 101 2980 2989 O
at 102 104 2990 2992 O
registration 105 117 2993 3005 O
until 118 123 3006 3011 O
at 124 126 3012 3014 O
least 127 132 3015 3020 O
3 133 134 3021 3022 B-lower_bound
months 135 141 3023 3029 I-lower_bound
after 142 147 3030 3035 O
the 148 151 3036 3039 O
last 152 156 3040 3044 O
dose 157 161 3045 3049 O
of 162 164 3050 3052 O
study 165 170 3053 3058 O
drug 171 175 3059 3063 O
; 175 176 3063 3064 O
the 177 180 3065 3068 O
definition 181 191 3069 3079 O
of 192 194 3080 3082 O
adequate 195 203 3083 3091 O
contraception 204 217 3092 3105 O
will 218 222 3106 3110 O
be 223 225 3111 3113 O
based 226 231 3114 3119 O
on 232 234 3120 3122 O
the 235 238 3123 3126 O
judgment 239 247 3127 3135 O
of 248 250 3136 3138 O
the 251 254 3139 3142 O
principal 255 264 3143 3152 O
investigator 265 277 3153 3165 O

Subjects 0 8 3166 3174 O
with 9 13 3175 3179 O
any 14 17 3180 3183 O
previously 18 28 3184 3194 O
untreated 29 38 3195 3204 O
or 39 41 3205 3207 O
concurrent 42 52 3208 3218 O
cancer 53 59 3219 3225 B-cancer
unrelated 60 69 3226 3235 O
to 70 72 3236 3238 O
angiosarcoma 73 85 3239 3251 B-cancer

Subjects 0 8 3252 3260 O
with 9 13 3261 3265 O
thrombotic 14 24 3266 3276 B-chronic_disease
, 24 25 3276 3277 O
embolic 26 33 3278 3285 B-chronic_disease
, 33 34 3285 3286 O
venous 35 41 3287 3293 O
, 41 42 3293 3294 O
or 43 45 3295 3297 O
arterial 46 54 3298 3306 O
events 55 61 3307 3313 O

Therapeutic 0 11 3314 3325 B-treatment
anticoagulation 12 27 3326 3341 I-treatment
with 28 32 3342 3346 I-treatment
Vitamin 33 40 3347 3354 I-treatment
- 40 41 3354 3355 I-treatment
K 41 42 3355 3356 I-treatment
antagonists 43 54 3357 3368 I-treatment
( 55 56 3369 3370 O
e.g. 56 60 3370 3374 O
, 60 61 3374 3375 O
warfarin 62 70 3376 3384 B-treatment
) 70 71 3384 3385 O
or 72 74 3386 3388 O
with 75 79 3389 3393 O
heparins 80 88 3394 3402 B-treatment
and 89 92 3403 3406 O
heparinoids 93 104 3407 3418 B-treatment

Total 0 5 3419 3424 O
bilirubin 6 15 3425 3434 B-clinical_variable
= 16 17 3435 3436 O
< 17 18 3436 3437 O
1.5 19 22 3438 3441 B-upper_bound
x 23 24 3442 3443 I-upper_bound
the 25 28 3444 3447 I-upper_bound
upper 29 34 3448 3453 I-upper_bound
limits 35 41 3454 3460 I-upper_bound
of 42 44 3461 3463 I-upper_bound
normal 45 51 3464 3470 I-upper_bound
( 52 53 3471 3472 I-upper_bound
ULN 53 56 3472 3475 I-upper_bound
) 56 57 3475 3476 I-upper_bound

Tumor 0 5 3477 3482 B-cancer
deemed 6 12 3483 3489 O
unresectable 13 25 3490 3502 O
or 26 28 3503 3505 O
metastatic 29 39 3506 3516 O

Uncontrolled 0 12 3517 3529 O
hypertension 13 25 3530 3542 B-chronic_disease
( 26 27 3543 3544 O
systolic 27 35 3544 3552 B-clinical_variable
pressure 36 44 3553 3561 I-clinical_variable
> 45 46 3562 3563 O
140 47 50 3564 3567 B-lower_bound
mmHg 51 55 3568 3572 I-lower_bound
or 56 58 3573 3575 O
diastolic 59 68 3576 3585 B-clinical_variable
pressure 69 77 3586 3594 I-clinical_variable
> 78 79 3595 3596 O
90 80 82 3597 3599 B-lower_bound
mmHg 83 87 3600 3604 I-lower_bound
on 88 90 3605 3607 O
repeated 91 99 3608 3616 O
measurement 100 111 3617 3628 O
) 111 112 3628 3629 O
despite 113 120 3630 3637 O
optimal 121 128 3638 3645 O
medical 129 136 3646 3653 O
management 137 147 3654 3664 O

Unstable 0 8 3665 3673 B-chronic_disease
angina 9 15 3674 3680 I-chronic_disease
( 16 17 3681 3682 O
anginal 17 24 3682 3689 O
symptoms 25 33 3690 3698 O
at 34 36 3699 3701 O
rest 37 41 3702 3706 O
) 41 42 3706 3707 O
, 42 43 3707 3708 O
new 44 47 3709 3712 O
- 47 48 3712 3713 O
onset 48 53 3713 3718 O
angina 54 60 3719 3725 O
within 61 67 3726 3732 O
3 68 69 3733 3734 B-upper_bound
months 70 76 3735 3741 I-upper_bound
before 77 83 3742 3748 O
registration 84 96 3749 3761 O
, 96 97 3761 3762 O
or 98 100 3763 3765 O
myocardial 101 111 3766 3776 B-chronic_disease
infarction 112 122 3777 3787 I-chronic_disease
within 123 129 3788 3794 O
6 130 131 3795 3796 B-upper_bound
months 132 138 3797 3803 I-upper_bound
before 139 145 3804 3810 O
registration 146 158 3811 3823 O

Use 0 3 3824 3827 O
of 4 6 3828 3830 O
cytotoxic 7 16 3831 3840 B-treatment
chemotherapy 17 29 3841 3853 I-treatment
within 30 36 3854 3860 O
21 37 39 3861 3863 B-upper_bound
days 40 44 3864 3868 I-upper_bound
of 45 47 3869 3871 O
registration 48 60 3872 3884 O

Use 0 3 3885 3888 O
of 4 6 3889 3891 O
targeted 7 15 3892 3900 B-treatment
therapy 16 23 3901 3908 I-treatment
within 24 30 3909 3915 O
two 31 34 3916 3919 B-upper_bound
half 35 39 3920 3924 I-upper_bound
- 39 40 3924 3925 I-upper_bound
lives 40 45 3925 3930 I-upper_bound
of 46 48 3931 3933 O
registration 49 61 3934 3946 O

Women 0 5 3947 3952 B-gender
of 6 8 3953 3955 O
childbearing 9 21 3956 3968 O
potential 22 31 3969 3978 O
must 32 36 3979 3983 O
have 37 41 3984 3988 O
a 42 43 3989 3990 O
negative 44 52 3991 3999 B-pregnancy
serum 53 58 4000 4005 I-pregnancy
pregnancy 59 68 4006 4015 I-pregnancy
test 69 73 4016 4020 I-pregnancy
performed 74 83 4021 4030 O
within 84 90 4031 4037 O
7 91 92 4038 4039 B-upper_bound
days 93 97 4040 4044 I-upper_bound
prior 98 103 4045 4050 I-upper_bound
to 104 106 4051 4053 O
the 107 110 4054 4057 O
start 111 116 4058 4063 O
of 117 119 4064 4066 O
study 120 125 4067 4072 O
drug 126 130 4073 4077 O

Women 0 5 4078 4083 B-gender
who 6 9 4084 4087 O
are 10 13 4088 4091 B-pregnancy
pregnant 14 22 4092 4100 I-pregnancy

all 0 3 4101 4104 O
treatments 4 14 4105 4115 O
must 15 19 4116 4120 O
have 20 24 4121 4125 O
been 25 29 4126 4130 O
completed 30 39 4131 4140 O
at 40 42 4141 4143 O
least 43 48 4144 4149 O
3 49 50 4150 4151 B-upper_bound
years 51 56 4152 4157 I-upper_bound
prior 57 62 4158 4163 I-upper_bound
to 63 65 4164 4166 O
registration 66 78 4167 4179 O

cerebrovascular 0 15 4180 4195 B-chronic_disease
accident 16 24 4196 4204 I-chronic_disease
( 25 26 4205 4206 O
including 26 35 4206 4215 O
transient 36 45 4216 4225 B-chronic_disease
ischemic 46 54 4226 4234 I-chronic_disease
attacks 55 62 4235 4242 I-chronic_disease
) 62 63 4242 4243 O
, 63 64 4243 4244 O
deep 65 69 4245 4249 B-chronic_disease
vein 70 74 4250 4254 I-chronic_disease
thrombosis 75 85 4255 4265 I-chronic_disease
or 86 88 4266 4268 O
pulmonary 89 98 4269 4278 B-chronic_disease
embolism 99 107 4279 4287 I-chronic_disease
within 108 114 4288 4294 O
6 115 116 4295 4296 B-upper_bound
months 117 123 4297 4303 I-upper_bound
of 124 126 4304 4306 O
informed 127 135 4307 4315 O
consent 136 143 4316 4323 O

doxorubicin 0 11 4324 4335 B-treatment
or 12 14 4336 4338 O
taxane 15 21 4339 4345 B-treatment
therapy 22 29 4346 4353 I-treatment
for 30 33 4354 4357 O
angiosarcoma 34 46 4358 4370 B-cancer

infrequent 0 10 4371 4381 O
bleeding 11 19 4382 4390 O
or 20 22 4391 4393 O
elevations 23 33 4394 4404 O
in 34 36 4405 4407 O
PT 37 39 4408 4410 B-treatment
- 39 40 4410 4411 I-treatment
INR 40 43 4411 4414 I-treatment
have 44 48 4415 4419 O
been 49 53 4420 4424 O
reported 54 62 4425 4433 O
in 63 65 4434 4436 O
some 66 70 4437 4441 O
subjects 71 79 4442 4450 O
taking 80 86 4451 4457 O
warfarin 87 95 4458 4466 B-treatment
while 96 101 4467 4472 O
on 102 104 4473 4475 O
regorafenib 105 116 4476 4487 B-treatment
therapy 117 124 4488 4495 I-treatment
; 124 125 4495 4496 O
therefore 126 135 4497 4506 O
, 135 136 4506 4507 O
subjects 137 145 4508 4516 O
taking 146 152 4517 4523 O
concomitant 153 164 4524 4535 B-treatment
warfarin 165 173 4536 4544 I-treatment
should 174 180 4545 4551 O
be 181 183 4552 4554 O
monitored 184 193 4555 4564 O
regularly 194 203 4565 4574 O
for 204 207 4575 4578 O
changes 208 215 4579 4586 O
in 216 218 4587 4589 O
PT 219 221 4590 4592 O
, 221 222 4592 4593 O
PT 223 225 4594 4596 O
- 225 226 4596 4597 O
INR 226 229 4597 4600 O
or 230 232 4601 4603 O
clinical 233 241 4604 4612 O
bleeding 242 250 4613 4621 O
episodes 251 259 4622 4630 O

patients 0 8 4631 4639 O
must 9 13 4640 4644 O
have 14 18 4645 4649 O
a 19 20 4650 4651 O
24 21 23 4652 4654 B-clinical_variable
- 23 24 4654 4655 I-clinical_variable
hour 24 28 4655 4659 I-clinical_variable
urine 29 34 4660 4665 I-clinical_variable
protein 35 42 4666 4673 I-clinical_variable
value 43 48 4674 4679 I-clinical_variable
< 49 50 4680 4681 O
grade 51 56 4682 4687 B-upper_bound
3 57 58 4688 4689 I-upper_bound
( 59 60 4690 4691 O
> 60 61 4691 4692 O
3.5 62 65 4693 4696 B-lower_bound
g/24 66 70 4697 4701 I-lower_bound
hours 71 76 4702 4707 I-lower_bound
) 76 77 4707 4708 O
to 78 80 4709 4711 O
be 81 83 4712 4714 O
eligible 84 92 4715 4723 O

post 0 4 4724 4728 O
- 4 5 4728 4729 O
menopausal 5 15 4729 4739 O
women 16 21 4740 4745 B-gender
( 22 23 4746 4747 O
defined 23 30 4747 4754 O
as 31 33 4755 4757 O
age 34 37 4758 4761 B-age
> 38 39 4762 4763 O
= 39 40 4763 4764 O
50 41 43 4765 4767 B-lower_bound
years 44 49 4768 4773 I-lower_bound
and 50 53 4774 4777 O
no 54 56 4778 4780 O
menses 57 63 4781 4787 O
for 64 67 4788 4791 O
at 68 70 4792 4794 O
least 71 76 4795 4800 O
1 77 78 4801 4802 B-lower_bound
year 79 83 4803 4807 I-lower_bound
) 83 84 4807 4808 O

subjects 0 8 4809 4817 O
surviving 9 18 4818 4827 O
a 19 20 4828 4829 O
cancer 21 27 4830 4836 O
that 28 32 4837 4841 O
was 33 36 4842 4845 O
curatively 37 47 4846 4856 O
treated 48 55 4857 4864 O
and 56 59 4865 4868 O
without 60 67 4869 4876 O
evidence 68 76 4877 4885 O
of 77 79 4886 4888 O
disease 80 87 4889 4896 O
for 88 91 4897 4900 O
more 92 96 4901 4905 O
than 97 101 4906 4910 O
3 102 103 4911 4912 B-lower_bound
years 104 109 4913 4918 I-lower_bound
before 110 116 4919 4925 O
registration 117 129 4926 4938 O
are 130 133 4939 4942 O
allowed 134 141 4943 4950 O

surgically 0 10 4951 4961 O
sterilized 11 21 4962 4972 O
women 22 27 4973 4978 B-gender
are 28 31 4979 4982 O
not 32 35 4983 4986 O
required 36 44 4987 4995 O
to 45 47 4996 4998 O
undergo 48 55 4999 5006 O
a 56 57 5007 5008 O
pregnancy 58 67 5009 5018 O
test 68 72 5019 5023 O

up 0 2 5024 5026 O
to 3 5 5027 5029 O
4 6 7 5030 5031 B-upper_bound
prior 8 13 5032 5037 B-treatment
therapies 14 23 5038 5047 I-treatment
are 24 27 5048 5051 O
allowed 28 35 5052 5059 O

